Cited by 357Retinal Diseases and TreatmentsGenetic Associations and EpidemiologyComplement system in diseases

Variation near complement factor I is associated with risk of advanced AMD

Open access
Fagerness, Jesen A, Maller, Julian B, Neale, Benjamin M, Reynolds, Robyn C, Daly, Mark J, Seddon, Johanna M·2009·European Journal of Human Genetics

Abstract

A case-control association study for advanced age-related macular degeneration was conducted to explore several regions of interest identified by linkage. This analysis identified a single nucleotide polymorphism just 3' of complement factor I on chromosome 4 showing significant association (P<10(-7)). Sequencing was performed on coding exons in linkage disequilibrium with the detected association. No obvious functional variation was discovered that could be the proximate cause of the association, suggesting a noncoding regulatory mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ejhg.2008.140

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genes in the complement pathway and a region of chromosome 10 have been implicated as the major genetic contributors to AMD.

    “Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
  • Several additional complement genes have now been strongly associated with AMD, including complement 2 and/or complement factor B, complement 3, and complement factor I.

    “These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
  • The role of the alternative complement pathway in AMD pathogenesis was documented by the discovery and replication of the CFH association and by reports of three additional risk loci in this pathway: CFB/C2 on chromosome 6, C3 on chromosome 19, and CFI on chromosome 4.

    “The role of the alternative complement pathway in disease pathogenesis was documented by the discovery ([2](#r2)–[5](#r5)) and replication ([6](#r6), [7](#r7)) of the *CFH* association as well as reports of three additional risk loci in this pathway: *CFB/C2* on chromosome 6 ([6](#r6), [8](#r8)), *C3* on chromosome 19 ([9](#r9), [10](#r10)), and *CFI* on chromosome 4 ([11](#r11)).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fagerness, J. A., Maller, J. B., Neale, B. M., Reynolds, R. C., Daly, M. J., & Seddon, J. M.
Affiliations
  • Massachusetts General Hospital (US)
  • Broad Institute (US)
  • Tufts Medical Center (US)
Corresponding author
Seddon, Johanna M
Venue
European Journal of Human Genetics
Published
2008-08-06
Volume
17
Issue
1
Pages
100-104
ISSN
  • 1018-4813 (ISSN-L)
  • 1476-5438
OpenAlex
W2092148373
Cited by
357
References
27
Citations by year
2026: 6 · 2025: 6 · 2024: 12 · 2023: 6 · 2022: 14 · 2021: 22 · 2020: 17 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 29 · 2014: 33 · 2013: 30 · 2012: 43
FWCI
27.02
Type
journal article
Language
en
Open access
Locations
  • European Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Foundation Fighting Blindness
  • Research to Prevent Blindness
  • Tufts Medical Center
  • Broad Institute
  • National Institutes of Health (6u54rr020278-06)
  • National Eye Institute (U10EY011309, EY11309, R01EY011309)
  • National Center for Research Resources (U54-RR020278)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Keywords
advanced age-related macular degeneration, complement factor I, CFI, single nucleotide polymorphisms, genetic association, chromosome 4, linkage disequilibrium, genetic susceptibility
MeSH terms
Aged, Chromosomes, Human, Pair 4, Female, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Linkage Disequilibrium, Case-Control Studies, Complement Factor I, Sequence Analysis, DNA, Risk Assessment, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review